Overview
Farhan Imran is a Hematologist Oncology specialist and a Hematologist in Rochester, New York. Dr. Imran and is rated as an Experienced provider by MediFind in the treatment of Alpha Thalassemia. His top areas of expertise are Squamous Cell Lung Carcinoma, Angiosarcoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Blue Cross Blue Shield
Locations
1425 Portland Ave, Rochester, NY 14621
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Rochester
Frank Akwaa is a Hematologist Oncology specialist and a Nurse Practitioner in Rochester, New York. Akwaa and is rated as an Advanced provider by MediFind in the treatment of Alpha Thalassemia. His top areas of expertise are Sickle Cell Disease, Monoclonal Gammopathy of Undetermined Significance (MGUS), Hemolytic-Uremic Syndrome, and D-Plus Hemolytic Uremic Syndrome.
Jeffrey Andolina is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Rochester, New York. Dr. Andolina has been practicing medicine for over 21 years and is rated as an Advanced provider by MediFind in the treatment of Alpha Thalassemia. His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Histiocytosis, Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Squamous Cell Lung Carcinoma
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Angiosarcoma
- Breast Cancer
- Childhood Acute Myeloid Leukemia
- End-Stage Renal Disease (ESRD)
- Lung Adenocarcinoma
- Experienced
- Adult Immune Thrombocytopenia
- Adult Soft Tissue Sarcoma
- Agranulocytosis
- Alpha Thalassemia
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- Alveolar Soft Part Sarcoma